TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06801002: Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

Sponsor: Jabez Bioscience, Inc · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 25 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$7,508,424

Rescue Site Savings

+$4,963,728

Unlock Full NCT06801002 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06801002 Rescue Dossier →